Itamar Medical Ltd. (ITMR)

Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of -63.33% and 0.98%, respectively, for the quarter ended September 2021.

Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

New York, New York--(Newsfile Corp. - September 13, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Itamar Medical Ltd. (NASDAQ: ITMR) ("Itamar" of the "Company") stock prior to September 13, 2021.You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Itamar with ZOLL Medical Corporation. ("ZOLL Medical"). Under t

ZOLL Medical isn't sleeping on the chance to acquire sleep apnea pioneer Itamar. Shares of ITMR stock are reacting well to the news.

Zoll Medical plans to acquire the small producer of medical devices.

The stock price of Itamar Medical (NASDAQ: ITMR) increased by over 40% pre-market. This is why it happened.

ZOLL Medical Corporation, an Asahi Kasei company, has agreed to acquire Itamar Medical Ltd (NASDAQ: ITMR) for a total value of approximately $538 million. Itamar Medical focuses on the development and commercialization of non-invasive medical devices and solutions to diagnose respiratory sleep disorders.

CHELMSFORD, Mass. & CAESAREA, Israel--(BUSINESS WIRE)--ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Itamar™ Medical Ltd. (Nasdaq and TASE: ITMR), a medical device and digital health company focused on the integration of sleep apnea diagnosis into the cardiac patient care pathway, today announced that the two companies signed a definitive agreement under which ZOLL Medical will acquire all outstanding ordinary shares of I

CAESAREA, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Marga Ortigas-Wedekind to its Board of Directors.

Itamar Medical Ltd.'s (ITMR) CEO Gilad Glick on Q2 2021 Results - Earnings Call Transcript

Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of 3.33% and 3.97%, respectively, for the quarter ended June 2021.

Shares of Itamar Medical (NASDAQ:ITMR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share decreased 17.65% year over year to ($0.20), which beat the estimate of ($0.29).

- Revenues Increased 41% Year-over-Year to $12.6 Million -

Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

CAESAREA, Israel, July 28, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that it will report its financial results for the second quarter 2021 before the U.S. market opens on Tuesday, August 10, 2021.

CAESAREA, Israel, June 30, 2021 (GLOBE NEWSWIRE) -- ItamarTM Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the company will present at the upcoming Ladenburg Thalmann Annual Healthcare Conference.